| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Al-Nawati tragedy: a 16-year-old patient with leukaemia and no access to cancer care
|
Amer, Faten
|
|
|
23 |
4 |
p. 447-449
|
artikel
|
| 2 |
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
|
Kindler, Hedy L
|
|
|
23 |
4 |
p. 540-552
|
artikel
|
| 3 |
ARCS-M: forging progress from this negative trial in malignant pleural mesothelioma
|
Zauderer, Marjorie G
|
|
|
23 |
4 |
p. 445-446
|
artikel
|
| 4 |
Cancer control in Botswana
|
Das, Manjulika
|
|
|
23 |
4 |
p. 455
|
artikel
|
| 5 |
Cancer detection, diagnosis, and treatment for adults with disabilities
|
Iezzoni, Lisa I
|
|
|
23 |
4 |
p. e164-e173
|
artikel
|
| 6 |
Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement
|
Sullivan, Richard
|
|
|
23 |
4 |
p. 460-462
|
artikel
|
| 7 |
Cancer treatment and decision making in individuals with intellectual disabilities: a scoping literature review
|
Boonman, Anne J
|
|
|
23 |
4 |
p. e174-e183
|
artikel
|
| 8 |
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
|
Tan, Darren Jun Hao
|
|
|
23 |
4 |
p. 521-530
|
artikel
|
| 9 |
Conflict in Ukraine and its impact on cancer care
|
The Lancet Oncology,
|
|
|
23 |
4 |
p. 439
|
artikel
|
| 10 |
Consequences of the crisis in Ukraine on cancer care
|
Burki, Talha Khan
|
|
|
23 |
4 |
p. 458
|
artikel
|
| 11 |
Consequences of US FDA approval decisions in high-income countries
|
Jenei, Kristina
|
|
|
23 |
4 |
p. e160
|
artikel
|
| 12 |
Correction to Lancet Oncol 2022; 23: 416–27
|
|
|
|
23 |
4 |
p. e161
|
artikel
|
| 13 |
Correction to Lancet Oncol 2022; 23: 382–92
|
|
|
|
23 |
4 |
p. e161
|
artikel
|
| 14 |
Correction to Lancet Oncol 2022; 23: 393–405
|
|
|
|
23 |
4 |
p. e161
|
artikel
|
| 15 |
Correction to Lancet Oncol 2022; 23: 501–13
|
|
|
|
23 |
4 |
p. e161
|
artikel
|
| 16 |
Decentralisation to improve cancer services in DR Congo
|
Das, Manjulika
|
|
|
23 |
4 |
p. 457
|
artikel
|
| 17 |
De-escalating elective nodal irradiation for nasopharyngeal carcinoma
|
Miller, Jacob A
|
|
|
23 |
4 |
p. 441-443
|
artikel
|
| 18 |
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial
|
Tang, Ling-Long
|
|
|
23 |
4 |
p. 479-490
|
artikel
|
| 19 |
ICGC-ARGO precision medicine: targeted therapy according to longitudinal assessment of tumour heterogeneity in colorectal cancer
|
Kotani, Daisuke
|
|
|
23 |
4 |
p. 463-464
|
artikel
|
| 20 |
Improving cancer care for people with disabilities
|
Reeves, Cheryl
|
|
|
23 |
4 |
p. 446-447
|
artikel
|
| 21 |
Inequality in childhood cancer care worldwide
|
Burki, Talha Khan
|
|
|
23 |
4 |
p. 456
|
artikel
|
| 22 |
Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials
|
Ottaiano, Alessandro
|
|
|
23 |
4 |
p. 452-454
|
artikel
|
| 23 |
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial
|
Dearnaley, David
|
|
|
23 |
4 |
p. 501-513
|
artikel
|
| 24 |
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
|
Delyon, Julie
|
|
|
23 |
4 |
p. 491-500
|
artikel
|
| 25 |
Pre-emptive or reactive? PROMPT spinal screening in metastatic castration-resistant prostate cancer
|
Siva, Shankar
|
|
|
23 |
4 |
p. 443-444
|
artikel
|
| 26 |
Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis
|
Vokinger, Kerstin N
|
|
|
23 |
4 |
p. 514-520
|
artikel
|
| 27 |
Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index
|
Viani, Gustavo A
|
|
|
23 |
4 |
p. 531-539
|
artikel
|
| 28 |
Pulling the investment levers on implementation research in oncology
|
Basu, Partha
|
|
|
23 |
4 |
p. 451-452
|
artikel
|
| 29 |
Qatar Red Crescent Society provides cancer drugs to the Palestinian Ministry of Health
|
Devi, Sharmila
|
|
|
23 |
4 |
p. 459
|
artikel
|
| 30 |
Quality of data from cancer registries in the Eastern Mediterranean region
|
Alkhalawi, Eman
|
|
|
23 |
4 |
p. 449-451
|
artikel
|
| 31 |
Radiation recall after COVID-19 infection
|
Ross, Richard Blake
|
|
|
23 |
4 |
p. e197
|
artikel
|
| 32 |
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC
|
Chang, Joe Y
|
|
|
23 |
4 |
p. e156
|
artikel
|
| 33 |
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC
|
Ochoa-de-Olza, Maria
|
|
|
23 |
4 |
p. e157
|
artikel
|
| 34 |
Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|
Marchak, Jordan Gilleland
|
|
|
23 |
4 |
p. e184-e196
|
artikel
|
| 35 |
Rucaparib for BRCA1/2-mutated pretreated ovarian cancer: reflections from the ARIEL4 trial
|
O'Donnell, Dearbhaile M
|
|
|
23 |
4 |
p. 440-441
|
artikel
|
| 36 |
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
|
Kristeleit, Rebecca
|
|
|
23 |
4 |
p. 465-478
|
artikel
|
| 37 |
Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC
|
Bi, Nan
|
|
|
23 |
4 |
p. e158
|
artikel
|
| 38 |
Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC – Author's reply
|
Wu, Yi-Long
|
|
|
23 |
4 |
p. e159
|
artikel
|
| 39 |
SSO 2022 International Conference on Surgical Cancer Care
|
Costa, Márcia
|
|
|
23 |
4 |
p. e163
|
artikel
|
| 40 |
2-week cancer target to be scrapped in England in overhaul of NHS standards
|
Wilkinson, Emma
|
|
|
23 |
4 |
p. e162
|
artikel
|
Tijdschrift beschrijving